Pfizer Inc DEFA14A, filed Mar 30, 2022
Pfizer Inc (PFE)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE 14A
Proxy
Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by
the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
| [_] | Preliminary Proxy Statement |
| [_] | CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by Rule 14a-6(e)(2)) |
| [_] | Definitive Proxy Statement |
| [X] | Definitive Additional Materials |
| [_] | Soliciting Material Pursuant to Section 240.14a-12 |
Pfizer Inc.
|
|
| (Name of Registrant as Specified In Its Charter) |
|
|
| (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) |
Payment of Filing Fee (Check all boxes that apply):
| [X] | No fee required. | |
| [_] | Fee paid previously with preliminary materials | |
| [_] | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | |
Margaret M. Madden
235 East 42nd Street, New York, NY 10017
YOUR VOTE IS IMPORTANT - PLEASE VOTE YOUR SHARES TODAY
Dear Fellow Pfizer Shareholder:
On April 28, 2022, Pfizer will hold its Annual Meeting of Shareholders. We value your input as a holder of Pfizer common stock and encourage you to review our proxy materials and cast your vote today. You can view our proxy materials at https://investors.pfizer.com/proxy.
For the reasons set forth in the 2022 Proxy Statement, the Board of Directors recommends that you vote:
| ● | “FOR” each director nominee |
| ● | “FOR” the ratification of the selection of KPMG LLP as the independent registered public accounting firm for 2022 |
| ● | “FOR” the 2022 advisory approval of executive compensation |
| ● | “AGAINST” the five shareholder proposals. |
For your convenience, a duplicate proxy/voting instruction card and return envelope are enclosed, along with telephone and Internet voting instructions. In the event that multiple proxies/voting instruction cards are received from you, the one with the latest date will be counted.
The 2022 Annual Meeting will be held in a virtual format only. Please view our proxy statement for details on how you can participate.
Your vote is important and valued. I encourage you to vote in advance of the Annual Meeting by one of the methods described in the proxy materials and duplicate proxy/voting instruction card. Please act today to be sure your shares are voted.
Sincerely,
Margaret M. Madden
Senior Vice President and Corporate Secretary, Chief Governance Counsel
Pfizer Inc. – Legal Division
| Breakthroughs that change patients’ lives | pfizer.com |